Skip to main navigation Skip to search Skip to main content

Microbiome in SARS-CoV-2 (Covid-19)

  • Subha Manoharan
  • , Lakshmi Thangavelu
  • , Mallineni Sreekanth Kumar
  • , Gaurav Gupta
  • , Kamal Dua
  • , Dinesh Kumar Chellappan
  • Madha Dental College & Hospital
  • Saveetha Institute of Medical and Technical Sciences (Deemed to be University)
  • Majmaah University
  • Suresh Gyan Vihar University
  • University of Technology Sydney
  • International Medical University

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Coronavirus was first identified in the year 1931 as avian infectious bronchitis virus (IBV). In 1966 and 1967, two new strains of virus causing human infection were identified (HCoV-229E and HCoV-OC43), respectively. Coronavirus is positive sense, single-stranded RNA virus with an envelope. It belongs to the family Coronaviridae, suborder Cornidovirineae and order Nidovirales. The initial havoc was due to the lack of understanding with the viral pathogenesis. As the pathogenesis became clear, the management protocol was designed with many tailor-made combinations suitable for the individual patient requirement.

Original languageEnglish
Title of host publicationMicrobiome in Inflammatory Lung Diseases
PublisherSpringer Nature
Pages281-294
Number of pages14
ISBN (Electronic)9789811689574
ISBN (Print)9789811689567
DOIs
StatePublished - 1 Jan 2022
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • COVID-19
  • Interleukin
  • MERS
  • Microbiome
  • Virus

Fingerprint

Dive into the research topics of 'Microbiome in SARS-CoV-2 (Covid-19)'. Together they form a unique fingerprint.

Cite this